Contact Us
|
Client Login
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Custom Immunology Services
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Discovery & Translational Services
Antibody Products
Biomarker Center of Excellence
BioPathways
Computational Biology
Genomics Laboratory
Immunology
Lead Optimization
Vaccines & Infectious Disease
Nonclinical Services
Antibody Products
Bioanalytical Services
Drug Metabolism & Pharmacokinetics
Immunology
Lead Optimization
Radiosynthesis
Research Models
Safety Pharmacology
Toxicology
Vaccines & Infectious Disease
Biopharmaceutical CMC Solutions
Biorepository Services
Environmental Sciences
Genomics Laboratory
Integration in Drug Development
Market Access
Nutritional Chemistry & Food Safety
Secure Data Access
Strategic Partnering
CAREERS
Search Jobs
College / University
Featured Jobs
Diversity
Benefits
现在就加入科文斯
STUDY PARTICIPANTS
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Industry Overview
History of Covance
Mission & Vision
Global Locations
Executive Leadership
Events
Corporate Responsibility
Supplier Code of Conduct
Business Integrity Program
Animal Welfare
Covance.Asia
RESOURCE CENTER
Blog
Investors
Investor Information
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
Home
> Investors >
Financial Information
>
Press Releases
Financial Information
Press Releases
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
Date
Title
21-May-2013
Covance Testing Method Named Industry Standard
Print
13-May-2013
Covance To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
Print
06-May-2013
Covance To Present At The R. W. Baird 2013 Growth Stock Conference
Print
01-May-2013
Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
Print
16-Apr-2013
Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients' Increased Asia Pacific Focus
Print
03-Apr-2013
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
Print
06-Mar-2013
Laboratory Recognized For Meeting Highest International Quality Standards
Print
26-Feb-2013
Covance and M2Gen® Enter into Alliance to Promote Faster Patient Recruitment in Biomarker-Driven Oncology Trials
Print
24-Jan-2013
Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
Print
17-Jan-2013
Covance and the Royal Liverpool and Broadgreen University Hospitals NHS Trust Establish Exclusive Agreement to Collaborate on Early Clinical Research
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Investigators
|
Covance.Asia
RSS
© Copyright 2013 Covance Inc. All rights reserved.